ContractConvertible Loan Agreement • November 18th, 2022 • CytoMed Therapeutics Pte. Ltd. • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.
SERVICE AGREEMENTService Agreement • November 18th, 2022 • CytoMed Therapeutics Pte. Ltd. • Pharmaceutical preparations
This Service Agreement (“Agreement”) is made of and entered into on 08th September 2021 between CytoMed Therapeutics (Malaysia) Sdn. Bhd. (“Company”) and Choo Chee Kong (“Service Provider”).
ContractPut Option Agreement • November 18th, 2022 • CytoMed Therapeutics Pte. Ltd. • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.
ContractLicence Agreement • November 18th, 2022 • CytoMed Therapeutics Pte. Ltd. • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.
ContractShareholders Agreement • November 18th, 2022 • CytoMed Therapeutics Pte. Ltd. • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.
ContractLicence Agreement • November 18th, 2022 • CytoMed Therapeutics Pte. Ltd. • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.
ContractLicence Agreement • November 18th, 2022 • CytoMed Therapeutics Pte. Ltd. • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.
ContractCytoMed Therapeutics Pte. Ltd. • November 18th, 2022 • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.
ContractSubscription Agreement • November 18th, 2022 • CytoMed Therapeutics Pte. Ltd. • Pharmaceutical preparations
Pursuant to Item 601(b)(10)(iv) of Regulation S-K, certain identified information marked with [*****] has been excluded from the exhibit because it is both (i) not material and (ii) the type that the registrant treats as private or confidential.
ADDENDUM TO LICENCE AGREEMENTLicence Agreement • November 18th, 2022 • CytoMed Therapeutics Pte. Ltd. • Pharmaceutical preparations
ACCELERATE TECHNOLOGIES PTE LTD, f.k.a.EXPLOIT TECHNOLOGIES PTE LTD (Co. Reg. No. 1995053187D), a company incorporated in Singapore and having its place of business at 1 Fusionopolis Way, #19-00 Connexis North, Singapore 138632 (hereinafter referred to as “A*ccelerate”) ; and
